IPP Bureau
Dr. Agarwals Eye Hospital inaugurates its third facility in Mysore
By IPP Bureau - March 07, 2025
This addition strengthens Dr. Agarwals Eye Hospital's vast network of 28 hospitals across Karnataka and 220+ facilities worldwide
Fermenta's plant-based Vitamin D3 is 'Innovation of the Year'
By IPP Bureau - March 07, 2025
VITADEETM Green is a 100% plant-based Vitamin D3 suitable for food & nutraceuticals
Biocon Biologics and Civica collaborate to expand Insulin Aspart access in US
By IPP Bureau - March 07, 2025
There are 38.4 million people with diabetes in the United States
India’s biotech economy set to reach a massive $300 bn by 2030: Dr. Jitendra Singh
By IPP Bureau - March 07, 2025
Biotech potential of Himalayan territories including Jammu & Kashmir, particularly their agri-biotech potential remains still under-explored
Briefs: Alembic Pharma and IOL Chemicals and Pharmaceuticals
By IPP Bureau - March 07, 2025
USFDA inspection at Alembic Pharma's Bioequivalence facility
Medicamen Biotech partners with South African business conglomerate
By IPP Bureau - March 07, 2025
The recent EU approval of MBL's plant has opened new avenues to explore such opportunities
Lupin Launches Rivaroxaban Tablets USP, 2.5mg in US
By IPP Bureau - March 07, 2025
Rivaroxaban Tablets USP, 2.5 mg, is bioequivalent to Xarelto® Tablets, 2.5 mg of Janssen Pharmaceuticals
J. B. Chemicals & Pharmaceuticals announces DJSI score of 77
By IPP Bureau - March 06, 2025
This achievement underscores the company’s steadfast commitment to sustainability, corporate responsibility, and ESG excellence
Zydus receives final approval from USFDA for Dasatinib Tablets
By IPP Bureau - March 06, 2025
Dasatinib is indicated for the treatment of newly diagnosed adults with Philadelphia chromosome-positive (Ph+) chronic myeloid leukaemia (CML) in chronic phase
Zydus Lifesciences launches ANVIMO
By IPP Bureau - March 06, 2025
ANVIMO will be available in dosages of 240 mg and 480 mg
Auro Vaccines terminates license agreement with Hilleman Laboratories Singapore
By IPP Bureau - March 06, 2025
This termination of Agreement will not have any significant impact on the company and/or its subsidiaries or its financials
Need for enhancing capacity building of medical officers to achieve desired results of healthcare schemes at the grassroot level: J. P. Nadda
By IPP Bureau - March 05, 2025
Nadda also commended the role of ASHA workers, “grassroot foot soldiers”, in the healthcare system
Unichem Laboratories receives 4 observations from USFDA for Pithampur API facility
By IPP Bureau - March 05, 2025
The company will provide the necessary response on these observations to USFDA within stipulated 15 days
Lucas Meyer Cosmetics by Clariant to launch honey-based skin repair solution ‘Melicica’
By IPP Bureau - March 05, 2025
Melicica has potential applications in skin repair, scar and acne-prone skin care, tone evening and brightening, texture improvement, baby care, sensitive skin solutions, post-procedure recovery and stretch mark care
